International multicentre randomised controlled trial of improvisational music therapy for children with autism spectrum disorder: TIME-A study
Mike J Crawford,Christian Gold,Helen Odell-Miller,Lavanya Thana,Sarah Faber,Jörg Assmus,Łucja Bieleninik,Monika Geretsegger,Claire Grant,Anna Maratos,Stephan Sandford,Amy Claringbold,Helen McConachie,Morag Maskey,Karin Antonia Mössler,Paul Ramchandani,Angela Hassiotis
DOI: https://doi.org/10.3310/hta21590
Abstract:Background: Preliminary studies have indicated that music therapy may benefit children with autism spectrum disorders (ASD). Objectives: To examine the effects of improvisational music therapy (IMT) on social affect and responsiveness of children with ASD. Design: International, multicentre, three-arm, single-masked randomised controlled trial, including a National Institute for Health Research (NIHR)-funded centre that recruited in London and the east of England. Randomisation was via a remote service using permuted blocks, stratified by study site. Setting: Schools and private, voluntary and state-funded health-care services. Participants: Children aged between 4 and 7 years with a confirmed diagnosis of ASD and a parent or guardian who provided written informed consent. We excluded children with serious sensory disorder and those who had received music therapy within the past 12 months. Interventions: All parents and children received enhanced standard care (ESC), which involved three 60-minute sessions of advice and support in addition to treatment as usual. In addition, they were randomised to either one (low-frequency) or three (high-frequency) sessions of IMT per week, or to ESC alone, over 5 months in a ratio of 1 : 1 : 2. Main outcome measures: The primary outcome was measured using the social affect score derived from the Autism Diagnostic Observation Schedule (ADOS) at 5 months: higher scores indicated greater impairment. Secondary outcomes included social affect at 12 months and parent-rated social responsiveness at 5 and 12 months (higher scores indicated greater impairment). Results: A total of 364 participants were randomised between 2011 and 2015. A total of 182 children were allocated to IMT (90 to high-frequency sessions and 92 to low-frequency sessions), and 182 were allocated to ESC alone. A total of 314 (86.3%) of the total sample were followed up at 5 months [165 (90.7%) in the intervention group and 149 (81.9%) in the control group]. Among those randomised to IMT, 171 (94.0%) received it. From baseline to 5 months, mean scores of ADOS social affect decreased from 14.1 to 13.3 in music therapy and from 13.5 to 12.4 in standard care [mean difference: music therapy vs. standard care = 0.06, 95% confidence interval (CI) -0.70 to 0.81], with no significant difference in improvement. There were also no differences in the parent-rated social responsiveness score, which decreased from 96.0 to 89.2 in the music therapy group and from 96.1 to 93.3 in the standard care group over this period (mean difference: music therapy vs. standard care = -3.32, 95% CI -7.56 to 0.91). There were seven admissions to hospital that were unrelated to the study interventions in the two IMT arms compared with 10 unrelated admissions in the ESC group. Conclusions: Adding IMT to the treatment received by children with ASD did not improve social affect or parent-assessed social responsiveness. Future work: Other methods for delivering music-focused interventions for children with ASD should be explored. Trial registration: Current Controlled Trials ISRCTN78923965. Funding: This project was funded by the NIHR Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 21, No. 59. See the NIHR Journals Library website for further project information.